Evidence map›Paper›PMID 31546673›Full record

ArticleMolecules (Basel, Switzerland)2019

Design and Synthesis of Novel 1,3-Thiazole and 2-Hydrazinyl-1,3-Thiazole Derivatives as Anti-

Andreea-Iulia Pricopie, Ioana Ionuț, Gabriel Marc, Anca-Maria Arseniu, Laurian Vlase, Adriana Grozav, Luiza Ioana Găină, Dan C Vodnar, Adrian Pîrnău, Brîndușa Tiperciuc and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Novel Isoxazole-Based Antifungal Drug Candidates.International journal of molecular sciences · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Thiazole Ring-A Biologically Active Scaffold.Molecules (Basel, Switzerland) · 2021
    Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Andreea-Iulia PricopieDepartment of Pharmaceutical Chemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania. pricopie.andreea@umfcluj.ro.
Ioana IonuțDepartment of Pharmaceutical Chemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania. ionut.ioana@umfcluj.ro.
Gabriel MarcDepartment of Pharmaceutical Chemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania. marc.gabriel@umfcluj.ro.ORCID 0000-0001-9397-0388
Anca-Maria ArseniuDepartment of Pharmaceutical Chemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania. borcea.anca@umfcluj.ro.
Laurian VlaseDepartment of Pharmaceutical Technology and Biopharmaceutics, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania. laurian.vlase@umfcluj.ro.ORCID 0000-0002-0664-3387
Adriana GrozavDepartment of Organic Chemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania. adriana.ignat@umfcluj.ro.
Luiza Ioana GăinăResearch Center on Fundamental and Applied Heterochemistry, Faculty of Chemistry and Chemical Engineering, "Babeş-Bolyai" University, 11 Arany Janos Street, 400028 Cluj-Napoca, Romania. lusi@chem.ubbcluj.ro.
Dan C VodnarDepartment of Food Science and Technology, University of Agricultural Sciences and Veterinary Medicine, 3-5 Mănăștur Street, 400372 Cluj-Napoca, Romania. dan.vodnar@usamvcluj.ro.ORCID 0000-0001-5407-8071
Adrian PîrnăuNational Institute for Research and Development of Isotopic and Molecular Technologies, 67-103 Donath Street, 400293 Cluj-Napoca, Romania. adrian.pirnau@itim-cj.ro.
Brîndușa TiperciucDepartment of Pharmaceutical Chemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania. brandu32@yahoo.com.ORCID 0000-0002-1333-5649
Ovidiu OnigaDepartment of Pharmaceutical Chemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania. onigao65@yahoo.com.
Iuliu Hațieganu University of Medicine and Pharmacy · ROBabeș-Bolyai University · ROLucian Blaga University of Sibiu · RONational Institute for Research and Development of Isotopic and Molecular Technologies · ROUniversity of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca · RO

Funding

"Iuliu Hațieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania 1531/7/18.01.2019Romanian Ministry of Research and Innovation Core Program, PN 19 35 02 01
6 · The paper itself

Abstract

In the context of there being a limited number of clinically approved drugs for the treatment of

Indexed as

Antifungal AgentsCandidaMolecular Docking SimulationSerum Albumin, BovineStructure-Activity RelationshipAntifungal AgentsSerum Albumin, Bovine1,3-thiazoleanti-Candidabovine serum albuminfluorescence quenchingmolecular docking

Identifiers

PMID31546673
PMCPMC6804233
OpenAlexW2974363744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.